Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 30.07.2024
BP p.l.c.
Top of page 1
FOR IMMEDIATE RELEASE
London 30 July 2024
BP p.l.c. Group results
Second quarter and first half 2024(a)
“For a printer friendly version of this announcement please click on the link below to open a PDF version of the announcement”
Strong cash generation, growing distributions
Financia [ … ]
Tue, 30.07.2024
Biotest AG
PRESS RELEASE
Biotest increases sales in the first half of 2024 by 35% to € 372 million
EBIT increased to € 78.4 million
FDA approval of Yimmugo® received in June 2024
FDA certification of the BNL production facility in Dreieich
Strategic distribution agreement with Kedrion is expected to generate revenues of more than
$1 billion for [ … ]
Tue, 30.07.2024
Basler AG
Corporate News
Basler AG acquires remaining shares of i2S's distribution business
Ahrensburg, July 30, 2024 – On August 1, 2024, Basler AG, a leading provider of image processing components for computer vision applications, acquires the remaining 74.9 percent of the distribution business of the former French distribution partner i2S. The joint [ … ]
Tue, 30.07.2024
The NAGA Group AG
The NAGA Group: Research update from SMC available – Upgrade to “BUY” recommendation and price target raised to EUR 1.60
Rating: BUYPrice target: EUR 1.60Upside to current share price: 97.5%Hamburg, 30 July 2024 – The NAGA GROUP AG (XETRA: N4G, ISIN: DE000A161NR7), is upgraded to “BUY” rating (previously: “SPECULATIVE BUY”) and raised to price targ [ … ]
Tue, 30.07.2024
Raiffeisen Bank International AG
Stable performance in the core business
H1/2024 consolidated profit of EUR 604 million, excluding Russia and Belarus and including
EUR 391 million provisions for CHF and EUR mortgage loans in Poland
Core revenues excluding Russia and Belarus stable at EUR 1,523 million quarter-over-quarter, slight margin-driven decrease in net interest income [ … ]
Tue, 30.07.2024
AEVIS VICTORIA SA
Ad hoc announcement pursuant to Art. 53 LR
Fribourg, 30 July 2024
AEVIS VICTORIA SA (AEVS:SW) achieved revenues of more than CHF 450 million in the first half-year 2024
AEVIS VICTORIA SA (AEVIS) continued its positive development and achieved revenues of more than CHF 450 million in the first six months of 2024, significantly up compared to the [ … ]
Tue, 30.07.2024
SIG Group AG
July 30, 2024
H1 2024 results
Quarter on quarter sequential improvement across KPIs
Q2 2024 revenue growth, at constant currency, +5.7% (constant currency and constant resin[1] +5.4%), following 0% growth in Q1 2024
HY 2024 revenue growth, at constant currency, +3.0% (constant currency and constant resin1 +2.9%)
Q2 2024 adjusted EBITDA margin [ … ]
Tue, 30.07.2024
FUCHS SE
FUCHS with good first half of 2024
Decrease in sales revenues of 3% to EUR 1.764 million due to price adjustments and
negative currency effects
EBIT improved by 9% or EUR 18 million to EUR 218 million
Earnings per share increases by 13% (preference share) or 14% (ordinary share);
share buyback program close to completion
Full-year outlook 202 [ … ]
Tue, 30.07.2024
Formycon AG
Press Release // July 30, 2024
Formycon announces start of clinical phase III trial for Keytruda® biosimilar candidate FYB206
Phase III “Lotus” trial compares safety and efficacy of FYB206 with reference drug Keytruda®1 (pembrolizumab)
The “Lotus” trial will involve the treatment of around 500 randomized NSCLC2 patients in various countries [ … ]
Tue, 30.07.2024
Avolta AG
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Supported by a strong global business model, Avolta reports for the sixth consecutive quarter a strong performance across all KPIs. In H1, the company delivers an impressive CORE turnover growth of +11.0%, organic growth of +7.1%, with EBITDA margin increasing by +40bps year-on-year to 9.0% and an EFCF of [ … ]